Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

An2 Therapeutics Inc (ANTX)

An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

An2 Therapeutics Inc 1300 El Camino Real Suite 100 MENLO PARK CA 94025 USA

www.an2therapeutics.com Employees: 22 P: 650-331-9090

Sector:

Medical

Description:

AN2 Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on developing treatments for rare, chronic and serious infectious diseases with high unmet needs. AN2 Therapeutics Inc. is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 32,334
Enterprise Value, $K 10,984
Shares Outstanding, K 27,402
Float, K 20,699
% Float 75.54%
Short Interest, K 45
Short Float 0.16%
Days to Cover 1.00
Short Volume Ratio 0.18
% of Insider Shareholders 24.46%
% of Institutional Shareholders 90.47%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -51,320 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,350 K
EBIT, $ -37,400 K
EBITDA, $ -40,680 K

Growth:

1-Year Return -3.97%
3-Year Return -90.61%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/12/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -1.12
EPS Growth vs. Prev Qtr -47.62%
EPS Growth vs. Prev Year 27.91%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -47.80%
Return-on-Assets % -42.95%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 2.21
Interest Coverage -2.15
60-Month Beta -0.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar